Drug Approval | September 09, 2021
Zydus Cadila gets US FDA approval for antidepressant tablets
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
Invega Hafyera offers patients the fewest doses per year. Phase 3 non-inferiority study results showed over 92% of participants were relapse-free at 12 months
Five seats reserved for Wards of COVID warriors in central MBBS admission
Sun Pharma has committed Rs. 100 crores towards these initiatives
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
Subscribe To Our Newsletter & Stay Updated
